Overexpression of PTENP1 significantly inhibited the proliferation, colony formation and migration of HNSCC cells and xenograft tumour growth, suggesting that that PTENP1 may be a novel therapeutic and prognostic target for HNSCC. Here, PTENP1 is linked to neoplasm.